Gamma Investing LLC Regeneron Pharmaceuticals, Inc. Transaction History
Gamma Investing LLC
- $18.8 Billion
- Q1 2025
A detailed history of Gamma Investing LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 815,620 shares of REGN stock, worth $492 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
815,620
Previous 907
89825.03%
Holding current value
$492 Million
Previous $646 Million
99.8%
% of portfolio
0.01%
Previous 0.06%
Shares
7 transactions
Others Institutions Holding REGN
# of Institutions
1,470Shares Held
88MCall Options Held
1.15MPut Options Held
1.39M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.68 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.1 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.26 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.92 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.86 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $64.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...